Trial Profile
A Randomized, Open-label, Single Center, Investigator-initiated Clinical Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Subjects With Mild to Moderate Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2017
Price :
$35
*
At a glance
- Drugs Asivatrep (Primary) ; Pimecrolimus
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors AmorePacific
- 10 Jan 2017 New trial record